Moderna MRNA Product Sales, Distribution Fees — Cost of Sales

Similar metrics at other companies

BBIOCost Of Goods Sold — Cost Of Revenue

$2.85M—

BBIONet product revenue — Cost of Revenue

$7.73M+280%

STEProduct — Cost of Product and Service Sold

$456.8M+5.4%

BIIBProduct revenue, net — Cost of sales, excluding amortization and impairment of acquired intangible assets

$478.7M+3.6%

ILMNProduct revenue — Cost of revenue

$197M-1.7%

TRMBProduct — Cost of Sales

$158.2M+10.1%

Questions, answered.

What is Moderna's product sales, distribution fees — cost of sales?

Moderna (MRNA) reported product sales, distribution fees — cost of sales of $0 in Q4 2022.

What does product sales, distribution fees — cost of sales mean?

The direct costs associated with manufacturing and delivering the company's commercial products to customers.

How do you interpret product sales, distribution fees — cost of sales?

A decrease in this metric relative to revenue indicates improved manufacturing efficiency or economies of scale, while an increase may signal rising production costs, supply chain disruptions, or shifts in product mix.

How does product sales, distribution fees — cost of sales compare across companies?

This is comparable to Cost of Goods Sold (COGS) in other pharmaceutical and biotech companies, though it may be influenced by specific mRNA manufacturing processes and cold-chain distribution requirements.